Biomarin Pharmaceutical Inc
LSE:0HNC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biomarin Pharmaceutical Inc
LSE:0HNC
|
US |
|
M
|
Murphy Oil Corp
XMUN:MUQ
|
US |
|
P
|
Ping An Insurance Group Co of China Ltd
XMUN:PZX
|
CN |
|
Systemair AB
STO:SYSR
|
SE |
|
A
|
American Tower Corp
F:A0T
|
US |
|
Katapult Holdings Inc
NASDAQ:KPLT
|
US |
|
P
|
Panasonic Holdings Corp
SWB:MATA
|
JP |
|
O
|
Oriental Land Co Ltd
OTC:OLCLY
|
JP |
Wall St Price Targets
0HNC Price Targets Summary
Biomarin Pharmaceutical Inc
According to Wall Street analysts, the average 1-year price target for 0HNC is 90.65 USD with a low forecast of 54.92 USD and a high forecast of 124.57 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0HNC's stock price target?
Price Target
90.65
USD
According to Wall Street analysts, the average 1-year price target for 0HNC is 90.65 USD with a low forecast of 54.92 USD and a high forecast of 124.57 USD.
What is the Revenue forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 9%.
What is the Operating Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
14%
The compound annual growth rate for Operating Income over the next 8 years is 14%.
What is the Net Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
27%
The compound annual growth rate for Net Income over the next 8 years is 27%.
